AMWL

NYSE Healthcare

American Well Corporation Class A Common Stock

Health Information Services

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

๐Ÿ“Š Market Data
Price$10.95
Volume103,419
Market Cap182.96M
Beta1.700
RSI (14-Day)76.5 Overbought
200-Day MA$6.03
50-Day MA$8.71
52-Week High$11.45
52-Week Low$3.71
Forward P/E-6.52
Price / Book0.80
๐ŸŽฏ Investment Strategy Scores

AMWL scores across each investment strategy. Higher is better for that strategy's goals.

๐Ÿ’ฐ Dividend Daddy 10/100โ–ผ -1
High dividend yield + low volatility
๐Ÿš€ Moon Shot 69/100โ–ฒ +2
High growth potential (high beta + oversold)
๐ŸŽˆ Over-Hyped 92/100โ–ผ -2
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐ŸŽˆ Over-Hyped (92/100) โ€” this strategy Overbought stocks (potential short candidates).

Lowest fit among scored strategies: ๐Ÿ‹ Institutional Whale (3/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find AMWL in your text

Paste any article, transcript, or post โ€” the tool will extract AMWL and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-07-16.